Trademark: 97281227
Status Date
Monday, April 8, 2024
Filing Date
Wednesday, February 23, 2022
Published for Opposition
Tuesday, July 11, 2023
Abandoned Date
Monday, April 8, 2024
5 Inhalers filled with prescription opioids, namely, FDA-approved opioids; Inhalers filled with pain relievers, namely, FDA-approved pain relievers
The mark consists of a stylized blue chevron design that features a series of blue circles across the body, on the upper left side of the chevron is a series of shaded circles in the colors blue, red, and purple.
The color(s) blue, red, and purple is/are claimed as a feature of the mark.
Apr 8, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 8, 2024
Abandonment - No Use Statement Filed
Mar 7, 2024
Teas Change Of Correspondence Received
Mar 7, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 7, 2024
Teas Change Of Owner Address Received
Mar 7, 2024
Withdrawal Of Attorney Granted
Mar 7, 2024
Teas Withdrawal Of Attorney Received
Sep 5, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 11, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2023
Published For Opposition
Jun 21, 2023
Notification Of Notice Of Publication E-Mailed
Jun 5, 2023
Law Office Publication Review Completed
May 27, 2023
Approved For Pub - Principal Register
May 8, 2023
Teas/Email Correspondence Entered
May 8, 2023
Correspondence Received In Law Office
May 8, 2023
Assigned To Lie
Feb 5, 2023
Teas Response To Office Action Received
Aug 9, 2022
Notification Of Non-Final Action E-Mailed
Aug 9, 2022
Non-Final Action E-Mailed
Aug 9, 2022
Non-Final Action Written
Jul 29, 2022
Assigned To Examiner
Mar 3, 2022
Notice Of Design Search Code E-Mailed
Mar 2, 2022
New Application Office Supplied Data Entered
Feb 26, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
